PATHOGENETICALLY TARGETED THERAPY FOR GASTROESOPHAGEAL REFLUX DISEASE

Download full text PDF
Issue: 
1
Year: 
2015

B. Starostin City Clinical Polyclinic Thirty-Eight, Saint Petersburg

The paper provides evidence that pathogenetically targeted therapy with a combination of a proton pump inhibitor and an alginate (Gaviscon® Double Action) should be used in gastroesophageal reflux disease.

Keywords: 
Gaviscon® Double Action
proton pump inhibitor
clinical
endoscopic
and histological remission



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Starostin B.D. Gastroezofageal'naja refljuksnaja bolezn' (chast' I). Epidemiologija, faktory riska // Gastroenterologija Sankt-Peterburga. – 2014; 1–2: 2–14.
  2. Kahrilas P. Gastroesophageal reflux disease // JAMA. – 1996; 276: 983–8.
  3. Starostin B.D. Gastroezofageal'naja refljuksnaja bolezn' // Rus. med. zhurn. – 1997; 5 (2): 72–80.
  4. Isakov V.A., Morozov S.V., Stavraki E.S. i dr. Analiz rasprostranennosti izzhogi: natsional'noe epidemiologicheskoe issledovanie vzroslogogorodskogo naselenija (ARIADNA) // Eksper. i klin. gastroenterol. – 2008; 1:20–9.
  5. Lazebnik L.B., Masharova A.A., Bordin D.S. i dr. Rezul'taty mnogotsen trovogo issledovanija «Epidemiologija gastroezofageal'noj refljuksnoj bolezni v Rossii» (MEGRE) // Ter. arh. – 2011; 16: 45–50.
  6. Starostin B.D. Gastroezofageal'naja refljuksnaja bolezn' (chast' II). Etiopatogenez, klinika, diagnostika // Gastroenterologija Sankt-Peterburga. – 2014; 3–4: 2–14.
  7. Tytgat G., McColl K., Tack J. et al. New algorithm for the treatment of gastrooesophageal reflux disease // Aliment. Pharmacol. Ther. – 2008; 27: 249–56.
  8. Fletcher J. et al. Unbuffered Highly Acidic Gastric Juice Exists at the Gastroesophageal Junction After a Meal // Gastroenterology. – 2001; 121: 775– 83.
  9. Beamont H., Bennink R., de Jong J. et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD // Gut. – 2010; 59 (4): 441–51.
  10. Namasiovayam V., Katzka D. Extraesophageal reflux Definition and Pathophysiology. In: AJ DiMarino Jr, S. Cohen, ed. Extraesophageal Manifestations of GERD. Slack Incorporated, 2013; 1–19.
  11. Clarke A., Wirz A., Manning J. et al. Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocket // Gut. – 2008; 57: 292–7.
  12. Pandolfino J. et al. Acidity Surrounding the Squamocolumnar Junction in GERD Patients: «Acid Pocket» Versus «Acid Film» // Am. J. Gastroenterol. – 2007; 102: 263–4.
  13. Kahrilas P. et al. The Acid Pocket: A Target for Treatment in Reflux Disease? // Am. J. Gastroenterol. – 2013; 108: 1058–64.
  14. Beaumont H., Boeckxstaens G. Scintigraphic imaging of the acid pocket: an enlarged pocket with acid coating the distal esophagus in GERD patients with hiatal hernia. 2009.
  15. Kahrilas P., Boeckxstaens G., Smout A. Management of the patient with incomplete response to PPI therapy // Best Practice & Res. Clin. Gastroenterol. – 2013; 27: 401–14.
  16. Manabe N., Haruma K., Ito M. et al. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial // Dis. Esophagus. – 2012; 25: 373–80.
  17. Chiu C.-T. et al. Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease // Aliment. Pharmacol. Ther. – 2013; 38 (9): 1054–64.
  18. Wang Y.-K. et al. Current Pharmacological Management of Gastroesophageal Reflux Disease // Gastroenterol Res. Pract. – 2013; http://dx.doi. org/10.1155/2013/983653
  19. Boeckxstaens G. et al. Symptomatic reflux disease: the present, the past and the future // Gut. – 2014; 63: 1185–93.